LAVA: Granular Neuron-Level Explainable AI for Alzheimer's Disease Assessment from Fundus Images

• URL: http://arxiv.org/abs/2302.03008v1
• Date: Mon, 6 Feb 2023 18:43:10 GMT
• Title: LAVA: Granular Neuron-Level Explainable AI for Alzheimer's Disease Assessment from Fundus Images
• Authors: Nooshin Yousefzadeh, Charlie Tran, Adolfo Ramirez-Zamora, Jinghua Chen, Ruogu Fang, My T. Thai
• Abstract summary: Alzheimer's Disease (AD) is a progressive neurodegenerative disease and the leading cause of dementia. The retina has been hypothesized as a diagnostic site for AD detection owing to its anatomical connection with the brain. We propose a novel model-agnostic explainable-AI framework, called Granular Neuron-level Explainer (LAVA)
• Score: 15.02513291695459
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Alzheimer's Disease (AD) is a progressive neurodegenerative disease and the leading cause of dementia. Early diagnosis is critical for patients to benefit from potential intervention and treatment. The retina has been hypothesized as a diagnostic site for AD detection owing to its anatomical connection with the brain. Developed AI models for this purpose have yet to provide a rational explanation about the decision and neither infer the stage of disease's progression. Along this direction, we propose a novel model-agnostic explainable-AI framework, called Granular Neuron-level Explainer (LAVA), an interpretation prototype that probes into intermediate layers of the Convolutional Neural Network (CNN) models to assess the AD continuum directly from the retinal imaging without longitudinal or clinical evaluation. This method is applied to validate the retinal vasculature as a biomarker and diagnostic modality for Alzheimer's Disease (AD) evaluation. UK Biobank cognitive tests and vascular morphological features suggest LAVA shows strong promise and effectiveness in identifying AD stages across the progression continuum.

Related papers

• MINDSETS: Multi-omics Integration with Neuroimaging for Dementia Subtyping and Effective Temporal Study [0.7751705157998379]
  Alzheimer's disease (AD) and vascular dementia (VaD) are the two most prevalent dementia types. This paper presents an innovative multi-omics approach to accurately differentiate AD from VaD, achieving a diagnostic accuracy of 89.25%.
  arXiv  Detail & Related papers  (2024-11-06T10:13:28Z)
• Towards Within-Class Variation in Alzheimer's Disease Detection from Spontaneous Speech [60.08015780474457]
  Alzheimer's Disease (AD) detection has emerged as a promising research area that employs machine learning classification models. We identify within-class variation as a critical challenge in AD detection: individuals with AD exhibit a spectrum of cognitive impairments. We propose two novel methods: Soft Target Distillation (SoTD) and Instance-level Re-balancing (InRe), targeting two problems respectively.
  arXiv  Detail & Related papers  (2024-09-22T02:06:05Z)
• Beyond the Eye: A Relational Model for Early Dementia Detection Using Retinal OCTA Images [42.75763279888966]
  We present a novel PolarNet+ that uses retinal optical coherence tomography angiography ( OCTA) to discriminate early-onset Alzheimer's disease (AD) and mild cognitive impairment (MCI) subjects from controls. Our method first maps OCTA images from Cartesian coordinates to polar coordinates, allowing approximate sub-region calculation. We then introduce a multi-view module to serialize and analyze the images along three dimensions for comprehensive, clinically useful information extraction.
  arXiv  Detail & Related papers  (2024-08-09T15:10:34Z)
• An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease [13.213387075528017]
  Alzheimer's disease (AD) is the most prevalent form of dementia with a progressive decline in cognitive abilities. In this study, we leveraged structural and functional MRI to investigate the disease-induced grey matter and functional network connectivity changes. We propose a novel deep learning-based classification framework where generative module employing Cycle GANs was adopted to impute missing data within the latent space.
  arXiv  Detail & Related papers  (2024-06-19T07:31:47Z)
• A Survey of Artificial Intelligence in Gait-Based Neurodegenerative Disease Diagnosis [51.07114445705692]
  neurodegenerative diseases (NDs) traditionally require extensive healthcare resources and human effort for medical diagnosis and monitoring. As a crucial disease-related motor symptom, human gait can be exploited to characterize different NDs. The current advances in artificial intelligence (AI) models enable automatic gait analysis for NDs identification and classification.
  arXiv  Detail & Related papers  (2024-05-21T06:44:40Z)
• Current and future roles of artificial intelligence in retinopathy of prematurity [14.333209377077058]
  Retinopathy of prematurity (ROP) is a severe condition affecting premature infants. Recent advancements in deep learning (DL), especially convolutional neural networks (CNNs) have significantly improved ROP detection and classification. The i-ROP deep learning (i-ROP-DL) system also shows promise in detecting plus disease, offering reliable ROP diagnosis potential.
  arXiv  Detail & Related papers  (2024-02-15T14:35:02Z)
• Leveraging Pretrained Representations with Task-related Keywords for Alzheimer's Disease Detection [69.53626024091076]
  Alzheimer's disease (AD) is particularly prominent in older adults. Recent advances in pre-trained models motivate AD detection modeling to shift from low-level features to high-level representations. This paper presents several efficient methods to extract better AD-related cues from high-level acoustic and linguistic features.
  arXiv  Detail & Related papers  (2023-03-14T16:03:28Z)
• Pathology Steered Stratification Network for Subtype Identification in Alzheimer's Disease [7.594681424335177]
  Alzheimers disease (AD) is a heterogeneous, multitemporal neurodegenerative disorder characterized by beta-amyloid, pathologic tau, and neurodegeneration. We propose a novel pathology steered stratification network (PSSN) that incorporates established domain knowledge in AD pathology through a reaction-diffusion model.
  arXiv  Detail & Related papers  (2022-10-12T02:52:00Z)
• Morphological feature visualization of Alzheimer's disease via Multidirectional Perception GAN [40.50404819220093]
  A novel Multidirectional Perception Generative Adversarial Network (MP-GAN) is proposed to visualize the morphological features indicating the severity of Alzheimer's disease (AD) MP-GAN achieves superior performance compared with the existing methods.
  arXiv  Detail & Related papers  (2021-11-25T03:24:52Z)
• Towards a quantitative assessment of neurodegeneration in Alzheimer's disease [0.0]
  Alzheimer's disease (AD) is an irreversible neurodegenerative disorder that progressively destroys memory and other cognitive domains of the brain. This paper introduces the notion of a pathology specific imaging contrast (PSIC), which can serve as a means of visual representation of the spatial extent of neurodegeneration. The values of PSIC are computed by a dedicated deep neural network (DNN), which has been specially adapted to the processing of dMRI signals.
  arXiv  Detail & Related papers  (2020-11-06T05:56:29Z)
• A Graph Gaussian Embedding Method for Predicting Alzheimer's Disease Progression with MEG Brain Networks [59.15734147867412]
  Characterizing the subtle changes of functional brain networks associated with Alzheimer's disease (AD) is important for early diagnosis and prediction of disease progression. We developed a new deep learning method, termed multiple graph Gaussian embedding model (MG2G) We used MG2G to detect the intrinsic latent dimensionality of MEG brain networks, predict the progression of patients with mild cognitive impairment (MCI) to AD, and identify brain regions with network alterations related to MCI.
  arXiv  Detail & Related papers  (2020-05-08T02:29:24Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.